ERK inhibitor XMD8-92, Purity ≥98%

Cat. No.: X23-10-ZQ870

ERK inhibitor XMD8-92, Purity ≥98%

Synonym: XMD8-92; 1234480-50-2; XMD 8-92; 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-B][1,4]benzodiazepin-6-one; 2-{[2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; ERK inhibitor

  • MDL: MFCD18782742
  • CAS Number: 1234480-50-2
  • Compound CID: 46843772
Product Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
XMD8-92, soluble in warmed DMSO and insoluble in water and ethanol, exhibits potent inhibition of ERK kinase. It targets ERK5.
Molecular Weight
474.55
Molecular Formula
C26H30N6O3
Targets
ERK5: 80 nM (Kd)
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 70 mg/mL (147.5 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
XMD8-92 can be used to investigate the effects of ERK5 inhibition in cellular signaling and cancer research.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0